Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology

References

• Poxton IR, McCoubrey J, Blair G. The pathogenicity of clostridium difficile. Clin Microbiol Infect. 2001;7(8):421–16. doi:10.1046/j.1198-743x.2001.00287.x.
   PubMed Web of Science ®Google Scholar
• Péchiné S, Bruxelle JF, Janoir C, Collignon A. Targeting clostridium difficile surface components to develop immunotherapeutic strategies against clostridium difficile infection. Front Microbiol. 2018;9:9. doi:10.3389/fmicb.2018.01009.
   PubMed Web of Science ®Google Scholar
• Fagan RP, Albesa-Jové D, Qazi O, Svergun DI, Brown KA, Fairweather NF. Structural insights into the molecular organization of the S-layer from clostridium difficile. Mol Microbiol. 2009;71(5):1308–1322. doi:10.1111/j.1365-2958.2009.06603.x.
   PubMed Web of Science ®Google Scholar
• Lanzoni-Mangutchi P, Banerji O, Wilson J, Barwinska-Sendra A, Kirk JA, Vaz F, O’Beirne S, Baslé A, El Omari K, Wagner A, et al. Structure and assembly of the S-layer in C. difficile. Nat Commun. 2022;13(1):970. doi:10.1038/s41467-022-28196-w.
   PubMed Web of Science ®Google Scholar
• Kirk JA, Gebhart D, Buckley AM, Lok S, Scholl D, Douce GR, Govoni GR, Fagan RP. New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability. Sci Transl Med. 2017;9(406):eaah6813. doi:10.1126/scitranslmed.aah6813.
   PubMed Web of Science ®Google Scholar
• Castro-Córdova P, Mora-Uribe P, Reyes-Ramírez R, Cofré-Araneda G, Orozco-Aguilar J, Brito-Silva C, Mendoza-León MJ, Kuehne SA, Minton NP, Pizarro-Guajardo M, et al. Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection. Nat Commun. 2021;12(1):1140. doi:10.1038/s41467-021-21355-5.
   PubMed Web of Science ®Google Scholar
• Meza-Torres J, Auria E, Dupuy B, Tremblay YDN. Wolf in sheep’s clothing: Clostridioides difficile biofilm as a reservoir for recurrent infections. Microorganisms. 2021;9(9):1922. doi:10.3390/microorganisms9091922.
   PubMed Web of Science ®Google Scholar
• Tremblay YDN, Hathroubi S, Jacques M. Bacterial biofilms: their importance in animal health and public health. Can J Vet Res. 2014;78(2):110–116. doi:10.1111/j.1462-2920.2012.02810.x.
   PubMed Web of Science ®Google Scholar
• Pantaléon V, Soavelomandroso AP, Bouttier S, Briandet R, Roxas B, Chu M, Collignon A, Janoir C, Vedantam G, Candela T, et al. The clostridium difficile protease Cwp84 modulates both biofilm formation and cell-surface properties. PloS ONE. 2015;10(4):e0124971. doi:10.1371/journal.pone.0124971.
   PubMed Web of Science ®Google Scholar
• Calabi E, Calabi F, Phillips AD, Fairweather NF. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun. 2002;70(10):5770–5778. doi:10.1128/IAI.70.10.5770-5778.2002.
   PubMed Web of Science ®Google Scholar
• Emanuela C, Franco C, PA D, FN F. Binding of clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun. 2002;70(10):5770–5778. doi:10.1128/IAI.70.10.5770-5778.2002.
   PubMed Web of Science ®Google Scholar
• Mizrahi A, Bruxelle JF, Péchiné S, Le Monnier A. Prospective evaluation of the adaptive immune response to SlpA in Clostridium difficile infection. Anaerobe. 2018;54:164–168. doi:10.1016/j.anaerobe.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Drudy D, Calabi E, Kyne L, Sougioultzis S, Kelly E, Fairweather N, Kelly CP. Human antibody response to surface layer proteins in Clostridium difficile infection. FEMS Immunol Med Microbiol. 2004;41(3):237–242. doi:10.1016/j.femsim.2004.03.007.
   PubMedGoogle Scholar
• Bruxelle JF, Mizrahi A, Hoys S, Collignon A, Janoir C, Péchiné S. Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models. Anaerobe. 2016;37:78–84. doi:10.1016/j.anaerobe.2015.10.010.
   PubMed Web of Science ®Google Scholar
• O’Brien JB, McCabe MS, Athié-Morales V, McDonald GSA, Ní Eidhin DB, Kelleher DP. Passive immunisation of hamsters against clostridium difficile infection using antibodies to surface layer proteins. FEMS Microbiol Lett. 2005;246(2):199–205. doi:10.1016/j.femsle.2005.04.005.
   PubMed Web of Science ®Google Scholar
• Kandalaft H, Hussack G, Aubry A, van Faassen H, Guan Y, Arbabi-Ghahroudi M, MacKenzie R, Logan SM, Tanha J. Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease. Appl Microbiol Biotechnol. 2015;99(20):8549–8562. doi:10.1007/s00253-015-6594-1.
   PubMed Web of Science ®Google Scholar
• Moor K, Fadlallah J, Toska A, Sterlin D, Balmer ML, Macpherson AJ, Gorochov G, Larsen M, Slack E. Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry. Nat Protoc. 2016;11(8):1531–1553. doi:10.1038/nprot.2016.091.
   PubMed Web of Science ®Google Scholar
• Lawley TD, Croucher NJ, Yu L, Clare S, Sebaihia M, Goulding D, Pickard DJ, Parkhill J, Choudhary J, Dougan G, et al. Proteomic and genomic characterization of highly infectious clostridium difficile 630 spores. J Bacteriol. 2009;191(17):5377–5386. doi:10.1128/JB.00597-09.
   PubMed Web of Science ®Google Scholar
• Jose S, Madan R. Neutrophil-mediated inflammation in the pathogenesis of clostridium difficile infections. Anaerobe. 2016;41:85–90. doi:10.1016/j.anaerobe.2016.04.001.
   PubMed Web of Science ®Google Scholar
• El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in clostridium difficile infection. Clin Infect Dis. 2013;56(12):1713–1721. doi:10.1093/cid/cit147.
   PubMed Web of Science ®Google Scholar
• Wang Y, Krémer V, Iannascoli B, Goff ORL, Mancardi DA, Ramke L, de Chaisemartin L, Bruhns P, Jönsson F. Specificity of mouse and human Fcgamma receptors and their polymorphic variants for IgG subclasses of different species. Eur J Immunol. 2022;52(5):753–759. doi:10.1002/eji.202149766.
   PubMed Web of Science ®Google Scholar
• Oatley P, Kirk JA, Ma S, Jones S, Fagan RP. Spatial organization of Clostridium difficile S-layer biogenesis. Sci Rep. 2020;10(1):14089. doi: 10.1038/s41598-020-71059-x.
   PubMed Web of Science ®Google Scholar
• Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the lactate dehydrogenase assay. Cold Spring Harb Protoc. 2018;2018(6):pdb.prot095497. doi:10.1101/pdb.prot095497.
   Google Scholar
• Usui Y, Ayibieke A, Kamiichi Y, Okugawa S, Moriya K, Tohda S, Saito R. Impact of deoxycholate on Clostridioides difficile growth, toxin production, and sporulation. Heliyon. 2020;6(4):e03717. doi:10.1016/j.heliyon.2020.e03717.
   PubMed Web of Science ®Google Scholar
• Dubois T, Tremblay YDN, Hamiot A, Martin-Verstraete I, Deschamps J, Monot M, Briandet R, Dupuy B. A microbiota-generated bile salt induces biofilm formation in Clostridium difficile. NPJ Biofilms Microbio. 2019;5(1):14. doi:10.1038/s41522-019-0087-4.
   PubMedGoogle Scholar
• Cohen SH, Tang YJ, Silva J Jr. Analysis of the pathogenicity locus in clostridium difficile strains. J Infect Dis. 2000;181(2):659–663. doi:10.1086/315248.
   PubMed Web of Science ®Google Scholar
• Lawry BM, Johnson CL, Flanagan K, Spoors JA, McNeil CJ, Wipat A, Keegan N. Species-specific detection of C. difficile using targeted antibody design. Anal Chem. 2018;90(22):13475–13482. doi:10.1021/acs.analchem.8b03349.
   PubMed Web of Science ®Google Scholar
• Péchiné S, Janoir C, Boureau H, Gleizes A, Tsapis N, Hoys S, Fattal E, Collignon A. Diminished intestinal colonization by clostridium difficile and immune response in mice after mucosal immunization with surface proteins of clostridium difficile. Vaccine. 2007;25(20):3946–3954. doi:10.1016/j.vaccine.2007.02.055.
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Van Hauwermeiren F, Van der Verren SE, Jonckheere W, Goncalves A, Pardon E, Steyaert J, De Greve H, Lamkanfi M, Remaut H. et al. Structure of S-layer protein Sap reveals a mechanism for therapeutic intervention in anthrax. Nat Microbiol. 2019;4(11):1805–1814. doi:10.1038/s41564-019-0499-1.
   PubMed Web of Science ®Google Scholar
• Majumdar A, Govind R. Regulation of Clostridioides difficile toxin production. Curr Opin Microbiol. 2022;65:95–100. doi:10.1016/j.mib.2021.10.018.
   PubMed Web of Science ®Google Scholar
• Govind R, Dupuy B, Cheung A. Secretion of Clostridium difficile toxins a and B requires the Holin-like protein TcdE. PloS Pathog. 2012;8(6):e1002727. doi:10.1371/journal.ppat.1002727.
   PubMed Web of Science ®Google Scholar
• Girinathan BP, Ou J, Dupuy B, Govind R, Koehler TM. Pleiotropic roles of Clostridium difficile sin locus. PloS Pathog. 2018;14(3):e1006940. doi:10.1371/journal.ppat.1006940.
   PubMed Web of Science ®Google Scholar
• Ciftci Y, Girinathan BP, Dhungel BA, Hasan MK, Govind R. Clostridioides difficile SinR’ regulates toxin, sporulation and motility through protein-protein interaction with SinR. Anaerobe. 2019;59:1–7. doi:10.1016/j.anaerobe.2019.05.002.
   PubMed Web of Science ®Google Scholar
• Bradshaw WJ, Kirby JM, Roberts AK, Shone CC, Acharya KR. Cwp2 from clostridium difficile exhibits an extended three domain fold and cell adhesion in vitro. FEBS J. 2017;284(17):2886–2898. doi:10.1111/febs.14157.
   PubMed Web of Science ®Google Scholar
• Vuotto C, Donelli G, Buckley A, Chilton C. Clostridium difficile Biofilm. Updates Clostridium Difficile Europe: Adv Microbiol, Infect Dis Public Health. 2018:97–115. doi:10.1007/978-3-319-72799-8_7.
   Google Scholar
• Soavelomandroso AP, Gaudin F, Hoys S, Nicolas V, Vedantam G, Janoir C, Bouttier S. Biofilm structures in a mono-associated mouse model of clostridium difficile infection. Front Microbiol. 2017;8:8. doi:10.3389/fmicb.2017.02086.
   PubMed Web of Science ®Google Scholar
• Normington C, Moura IB, Bryant JA, Ewin DJ, Clark EV, Kettle MJ, Harris HC, Spittal W, Davis G, Henn MR, et al. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. NPJ Biofilms Microbio. 2021;7(1):16. doi:10.1038/s41522-021-00184-w.
   PubMed Web of Science ®Google Scholar
• Semenyuk EG, Laning ML, Foley J, Johnston PF, Knight KL, Gerding DN, Driks A. Spore formation and toxin production in clostridium difficile biofilms. PloS ONE. 2014;9(1):e87757. doi:10.1371/journal.pone.0087757.
   PubMed Web of Science ®Google Scholar
• Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW, Popoff MR. Characterisation of clostridium difficile biofilm formation, a role for Spo0A. PloS ONE. 2012;7(12):e50527. doi:10.1371/journal.pone.0050527.
   PubMed Web of Science ®Google Scholar
• Beganović J, Frece J, Kos B, Leboš Pavunc A, Habjanič K, Šušković J. Functionality of the S-layer protein from the probiotic strain Lactobacillus helveticus M92. Antonie Van Leeuwenhoek. 2011;100(1):43–53. doi:10.1007/s10482-011-9563-4.
   PubMed Web of Science ®Google Scholar
• Brauer M, Lassek C, Hinze C, Hoyer J, Becher D, Jahn D, Sievers S, Riedel K. What’s a biofilm?—how the choice of the biofilm model impacts the protein inventory of Clostridioides difficile. Front Microbiol. 2021;12:12. doi:10.3389/fmicb.2021.682111.
   Web of Science ®Google Scholar
• Taggart MG, Snelling WJ, Naughton PJ, La Ragione RM, Dooley JSG, Ternan NG, Blumenthal A. Biofilm regulation in Clostridioides difficile: novel systems linked to hypervirulence. PloS Pathog. 2021;17(9):e1009817. doi:10.1371/journal.ppat.1009817.
   PubMed Web of Science ®Google Scholar
• Rollenske T, Burkhalter S, Muerner L, von Gunten S, Lukasiewicz J, Wardemann H, Macpherson AJ. Parallelism of intestinal secretory IgA shapes functional microbial fitness. Nature. 2021;598(7882):657–661. doi:10.1038/s41586-021-03973-7.
   PubMed Web of Science ®Google Scholar
• Macdonald LE, Karow M, Stevens S, Auerbach W, Poueymirou WT, Yasenchak J, Frendewey D, Valenzuela DM, Giallourakis CC, Alt FW, et al. Precise and in situ genetic humanization of 6 mb of mouse immunoglobulin genes. Proc Natl Acad Sci USA. 2014;111(14):5147–5152. doi:10.1073/pnas.1323896111.
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Macdonald LE, Stevens S, Karow M, Dore AT, Pobursky K, Huang TT, Poueymirou WT, Esau L, Meola M, et al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci USA. 2014;111(14):5153–5158. doi:10.1073/pnas.1324022111.
   PubMed Web of Science ®Google Scholar
• Balbino B, Herviou P, Godon O, Stackowicz J, Goff ORL, Iannascoli B, Sterlin D, Brûlé S, Millot GA, Harris FM, et al. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. J Clin Invest. 2020;130(3):1330–1335. doi:10.1172/JCI129697.
   PubMed Web of Science ®Google Scholar
• Hussain HA, Roberts AP, Mullany P. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Δerm) and demonstration that the conjugative transposon Tn916ΔE enters the genome of this strain at multiple sites. J Med Microbiol. 2005;54(2):137–141. doi:10.1099/jmm.0.45790-0.
   PubMed Web of Science ®Google Scholar
• Babakhani F, Bouillaut L, Gomez A, Sears P, Nguyen L, Sonenshein AL. Fidaxomicin inhibits spore production in clostridium difficile. Clin Infect Dis. 2012;55(suppl_2):S162–S169. doi:10.1093/cid/cis453.
   PubMedGoogle Scholar
• Hartmann R, Jeckel H, Jelli E, Singh PK, Vaidya S, Bayer M, Rode DKH, Vidakovic L, Díaz-Pascual F, Fong JCN, et al. Quantitative image analysis of microbial communities with BiofilmQ. Nat Microbiol. 2021;6(2):151–156. doi:10.1038/s41564-020-00817-4.
   PubMed Web of Science ®Google Scholar